Quick Answer
ASSEMBLY BIOSCIENCES, INC. reported Total Revenue of $72.30 million for fiscal year 2025.
ASSEMBLY BIOSCIENCES, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $72.30M | +153.5% |
| 2024 | $28.52M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| March 31, 2019 | $3.88M | +9.0% | -9.4% |
| September 30, 2018 | $4.29M | +61.1% | +33.2% |
| June 30, 2018 | $3.22M | +36.4% | -9.7% |
| March 31, 2018 | $3.56M | — | +34.0% |
| September 30, 2017 | $2.66M | — | +12.7% |
| June 30, 2017 | $2.36M | — | — |
- ASSEMBLY BIOSCIENCES, INC. showed an increase of +153.5% in Total Revenue compared to the prior fiscal year.
- Over the 2024–2025 period, ASSEMBLY BIOSCIENCES, INC.’s total revenue has grown by 153.5% (from $28.52 million to $72.30 million).
- The most recent figure is from ASSEMBLY BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: